Loestrin 24 Fe Ad Campaign Targets Consumers Not Currently On Birth Control
This article was originally published in The Pink Sheet Daily
Executive Summary
Ads for Warner Chilcott’s 24-day oral contraceptive debuted May 15, directing consumers to studies demonstrating a shorter period duration.
You may also be interested in...
Berlex’ YAZ Clears FDA For Contraception; April Launch Planned
A premenstrual dysphoric disorder indication for the low-dose version of Yasmin is still pending.
Loestrin 24 Approved As First 24-Day Oral Contraceptive
Warner Chilcott beats out Berlex' Yaz as the first oral contraceptive approved in the U.S. with 24 active hormone days.
Raising Corporate Taxes Would Put US Investment At Risk, J&J CFO Warns
"I don't know why folks are anxious to have a race to the top in terms of rates," Joseph Wolk ways. After US tax reform in 2017, lowering the standard tax rate from 35% to 21%, J&J committed to increasing US investment 15% over the next four years.